총 50 건의 최근 내부자 거래 내역가 기록되었습니다 Iovance Biotherapeutics, Inc. (IOVA), 포함 20 건 매수 및 28 건 매도. 내부자 매수 총액은 $107.19K 내부자 매도 총액은 $50.63K.
최근 활동이 있는 주요 내부자에는 Bilinsky Igor, Vogt Frederick G, Graf Finckenstein Friedrich. 내부자 거래 내역는 경영진이 주식의 가치와 미래 전망을 어떻게 보는지에 대한 통찰을 제공할 수 있습니다.
내부자 거래 내역 — IOVA
| 날짜 |
이름 |
직책 |
거래 유형 |
주식수 |
평균 가격 |
금액 |
보유 주식수 |
| 2026-03-09 |
Bilinsky Igor |
Chief Operating Officer |
RSU 부여 |
117,500 |
- |
- |
117,500 |
| 2026-03-09 |
Vogt Frederick G |
Interim CEO & General Counsel |
RSU 부여 |
235,000 |
- |
- |
235,000 |
| 2026-03-09 |
Graf Finckenstein Friedrich |
Chief Medical Officer |
RSU 부여 |
58,750 |
- |
- |
58,750 |
| 2026-03-09 |
Roche Corleen M. |
Chief Financial Officer |
RSU 부여 |
132,200 |
- |
- |
132,200 |
| 2026-03-09 |
Puri Raj K. |
Chief Regulatory Officer |
RSU 부여 |
117,500 |
- |
- |
117,500 |
| 2026-03-09 |
Kirby Daniel Gordon |
Chief Commercial Officer |
RSU 부여 |
132,200 |
- |
- |
132,200 |
| 2026-03-05 |
Bilinsky Igor |
Chief Operating Officer |
옵션 행사 (매도) |
31,246 |
- |
- |
62,504 |
| 2026-03-05 |
Vogt Frederick G |
Interim CEO & General Counsel |
옵션 행사 (매도) |
62,493 |
- |
- |
125,007 |
| 2026-03-05 |
Graf Finckenstein Friedrich |
Chief Medical Officer |
옵션 행사 (매도) |
31,246 |
- |
- |
62,504 |
| 2026-03-05 |
Puri Raj K. |
Chief Regulatory Officer |
옵션 행사 (매도) |
39,059 |
- |
- |
78,131 |
| 2026-03-02 |
Bilinsky Igor |
Chief Operating Officer |
옵션 행사 (매도) |
3,517 |
- |
- |
- |
| 2026-03-02 |
Vogt Frederick G |
Interim CEO & General Counsel |
옵션 행사 (매도) |
10,418 |
- |
- |
- |
| 2026-03-02 |
Graf Finckenstein Friedrich |
Chief Medical Officer |
옵션 행사 (매도) |
3,907 |
- |
- |
- |
| 2026-03-02 |
Puri Raj K. |
Chief Regulatory Officer |
옵션 행사 (매도) |
5,470 |
- |
- |
21,878 |
| 2026-02-24 |
Kirby Daniel Gordon |
Chief Commercial Officer |
옵션 행사 (매도) |
150,000 |
- |
- |
- |
| 2026-02-10 |
Kirby Daniel Gordon |
Chief Commercial Officer |
RSU 원천징수 |
16,450 |
$2.60 |
$42.77K |
53,546 |
| 2025-12-02 |
Bilinsky Igor |
Chief Operating Officer |
옵션 행사 (매도) |
3,516 |
- |
- |
3,517 |
| 2025-12-02 |
Vogt Frederick G |
Interim CEO & General Counsel |
옵션 행사 (매도) |
10,417 |
- |
- |
10,418 |
| 2025-12-02 |
Graf Finckenstein Friedrich |
Chief Medical Officer |
옵션 행사 (매도) |
3,906 |
- |
- |
3,907 |
| 2025-12-01 |
Bilinsky Igor |
Chief Operating Officer |
옵션 행사 (매도) |
8,789 |
- |
- |
43,949 |
| 2025-12-01 |
Vogt Frederick G |
Interim CEO & General Counsel |
옵션 행사 (매도) |
41,669 |
- |
- |
208,344 |
| 2025-12-01 |
Graf Finckenstein Friedrich |
Chief Medical Officer |
옵션 행사 (매도) |
8,789 |
- |
- |
43,949 |
| 2025-12-01 |
Puri Raj K. |
Chief Regulatory Officer |
옵션 행사 (매도) |
5,469 |
- |
- |
27,348 |
| 2025-09-02 |
Bilinsky Igor |
Chief Operating Officer |
옵션 행사 (매도) |
3,516 |
- |
- |
7,033 |
| 2025-09-02 |
Vogt Frederick G |
Interim CEO & General Counsel |
옵션 행사 (매도) |
10,417 |
- |
- |
20,385 |
| 2025-09-02 |
Graf Finckenstein Friedrich |
Chief Medical Officer |
옵션 행사 (매도) |
3,907 |
- |
- |
7,813 |
| 2025-09-02 |
Puri Raj K. |
Chief Regulatory Officer |
옵션 행사 (매도) |
5,470 |
- |
- |
32,817 |
| 2025-08-06 |
Roche Corleen M. |
Officer |
알 수 없음 |
- |
- |
- |
- |
| 2025-08-06 |
Roche Corleen M. |
Chief Financial Officer |
RSU 부여 |
150,000 |
- |
- |
150,000 |
| 2025-06-30 |
Rosinack Matthew W. |
SVP, Finance (int. Pfo & Pao) |
알 수 없음 |
75,000 |
$25.30 |
$1.9M |
- |
| 2025-06-13 |
Yarno Wendy L |
Director |
RSU 부여 |
67,546 |
- |
- |
67,546 |
| 2025-06-13 |
Weiser Michael |
Director |
RSU 부여 |
67,546 |
- |
- |
67,546 |
| 2025-06-13 |
Maynard Ryan D |
Director |
RSU 부여 |
67,546 |
- |
- |
67,546 |
| 2025-06-13 |
Countouriotis Athena |
Director |
RSU 부여 |
67,546 |
- |
- |
67,546 |
| 2025-06-13 |
Dukes Iain D. |
Director |
RSU 부여 |
135,092 |
- |
- |
135,092 |
| 2025-06-05 |
Kirby Daniel Gordon |
Chief Commercial Officer |
정보 매수 |
30,000 |
$1.84 |
$55.2K |
30,000 |
| 2025-06-02 |
Bilinsky Igor |
Chief Operating Officer |
옵션 행사 (매도) |
3,516 |
- |
- |
10,549 |
| 2025-06-02 |
Vogt Frederick G |
Interim CEO & General Counsel |
옵션 행사 (매도) |
10,417 |
- |
- |
31,252 |
| 2025-06-02 |
Bellemin Jean-marc |
Chief Financial Officer |
RSU 원천징수 |
4,464 |
$1.76 |
$7.86K |
60,529 |
| 2025-06-02 |
Graf Finckenstein Friedrich |
Chief Medical Officer |
옵션 행사 (매도) |
3,906 |
- |
- |
11,720 |
| 2025-06-02 |
Puri Raj K. |
Chief Regulatory Officer |
옵션 행사 (매도) |
5,469 |
- |
- |
38,287 |
| 2025-05-23 |
Puri Raj K. |
Chief Regulatory Officer |
정보 매수 |
5,600 |
$1.74 |
$9.74K |
206,852 |
| 2025-05-14 |
Vogt Frederick G |
Interim CEO & General Counsel |
정보 매수 |
25,000 |
$1.69 |
$42.25K |
374,646 |
| 2025-03-14 |
Puri Raj K. |
Chief Regulatory Officer |
옵션 행사 (매도) |
8,334 |
- |
- |
- |
| 2025-03-05 |
Bilinsky Igor |
Chief Operating Officer |
RSU 부여 |
93,750 |
- |
- |
93,750 |
| 2025-03-05 |
Vogt Frederick G |
Interim CEO & General Counsel |
RSU 부여 |
187,500 |
- |
- |
187,500 |
| 2025-03-05 |
Bellemin Jean-marc |
Chief Financial Officer |
RSU 부여 |
93,750 |
- |
- |
93,750 |
| 2025-03-05 |
Graf Finckenstein Friedrich |
Chief Medical Officer |
RSU 부여 |
93,750 |
- |
- |
93,750 |
| 2025-03-05 |
Puri Raj K. |
Chief Regulatory Officer |
RSU 부여 |
117,190 |
- |
- |
117,190 |
| 2025-03-03 |
Bilinsky Igor |
Chief Operating Officer |
옵션 행사 (매도) |
3,516 |
- |
- |
14,065 |
■ 정보 기반 — 공개 시장 거래 (가장 중요)
■ 비정보 매수 — 보상, 옵션 행사, 전환
■ 비정보 매도 — 세금 원천징수, 부여 매도
■ 중립 — 증여, 신탁, 만료
